当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析

天康生物

(002100)

  

流通市值:100.48亿  总市值:100.48亿
流通股本:13.65亿   总股本:13.65亿

天康生物(002100)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-1.73亿元,每股收益-0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益844170.71万元,未分配利润93344.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1804326.14万元,负债960155.43万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入3,916,826,741.9416,981,074,699.2613,610,370,203.128,846,725,199.5
营业总成本4,059,490,050.2516,576,749,906.3913,098,483,091.048,435,393,584.63
其他经营收益
营业利润-154,989,363.3322,209,571.62502,001,579.92403,950,602.49
利润总额-163,688,307.21328,109,399.22515,393,523.15420,984,340.33
净利润-172,508,165.96300,308,190.47504,865,088.26409,618,129.4
每股收益
其他综合收益77,495,593.3913,946,007.742,755,441.21-25,190,790.19
综合收益总额-95,012,572.57314,254,198.17547,620,529.47384,427,339.21
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计10,789,449,984.819,949,972,555.79,405,897,554.038,776,473,163.57
非流动资产:
非流动资产合计7,253,811,412.747,441,222,454.027,410,944,996.587,466,013,773.77
资产总计18,043,261,397.5517,391,195,009.7216,816,842,550.6116,242,486,937.34
流动负债:
流动负债合计6,603,728,107.986,494,788,633.185,434,542,104.085,543,641,728.36
非流动负债:
非流动负债合计2,997,826,203.742,359,686,036.022,614,823,227.262,095,205,873.48
负债合计9,601,554,311.728,854,474,669.28,049,365,331.347,638,847,601.84
所有者权益(或股东权益):
归属于母公司股东权益合计6,858,967,727.176,941,275,931.637,170,426,280.417,028,287,241.17
股东权益合计8,441,707,085.838,536,720,340.528,767,477,219.278,603,639,335.5
负债和股东权益合计18,043,261,397.5517,391,195,009.7216,816,842,550.6116,242,486,937.34
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计4,176,903,967.8918,188,368,519.6213,373,823,339.428,820,950,257.06
经营活动现金流出小计3,445,532,234.1517,807,506,779.6911,023,244,308.917,201,924,795.7
经营活动产生的现金流量净额731,371,733.74380,861,739.932,350,579,030.511,619,025,461.36
投资活动产生的现金流量:
投资活动现金流入小计264,656,811.64371,453,904.98686,699.99686,699.99
投资活动现金流出小计180,668,974.731,658,901,069.51243,060,965.55179,118,903.51
投资活动产生的现金流量净额83,987,836.91-1,287,447,164.53-242,374,265.56-178,432,203.52
筹资活动产生的现金流量:
筹资活动现金流入小计1,450,000,0005,366,359,410.223,416,687,240.221,270,987,240.22
筹资活动现金流出小计1,223,867,140.996,002,460,516.034,637,457,733.072,855,507,964.66
筹资活动产生的现金流量净额226,132,859.01-636,101,105.81-1,220,770,492.85-1,584,520,724.44
汇率变动对现金及现金等价物的影响--47,027.52--
现金及现金等价物净增加额1,041,492,429.66-1,542,733,557.93887,434,272.1-143,927,466.6
期末现金及现金等价物余额2,452,321,421.631,410,828,991.973,560,019,371.522,809,635,083.3
补充资料:
现金及现金等价物的净增加额--1,542,733,557.93--143,927,466.6
最新报告期:2026-05-13
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券盛夏,彭家乐-0.330.960.552026-05-13
中金公司王思洋,龙友琪0.020.28--2026-05-01
开源证券陈雪丽0.080.450.552026-05-01
中国银河谢芝优0.080.971.032026-04-29
TOP↑